HCP & DTC

Zelboraf

Zelboraf was the first ever personalised treatment for metastatic melanoma. Before Zelboraf, patients were essentially treated as one group - all the same, but with Zelboraf, patients could be individually identified as being receptive to treatment or not, significantly increasing the likelihood of a positive result.